GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (LTS:0I0L) » Definitions » Cash-to-Debt

Labo Euromedis (LTS:0I0L) Cash-to-Debt : 1.88 (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Labo Euromedis Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Labo Euromedis's cash to debt ratio for the quarter that ended in Jun. 2023 was 1.88.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Labo Euromedis could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Labo Euromedis's Cash-to-Debt or its related term are showing as below:

LTS:0I0L' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09   Med: 0.2   Max: 2.16
Current: 1.88

During the past 14 years, Labo Euromedis's highest Cash to Debt Ratio was 2.16. The lowest was 0.09. And the median was 0.20.

LTS:0I0L's Cash-to-Debt is ranked worse than
50.23% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.895 vs LTS:0I0L: 1.88

Labo Euromedis Cash-to-Debt Historical Data

The historical data trend for Labo Euromedis's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Labo Euromedis Cash-to-Debt Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.89 2.05 2.09 1.88

Labo Euromedis Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 2.16 2.09 1.88 1.88

Competitive Comparison of Labo Euromedis's Cash-to-Debt

For the Medical Devices subindustry, Labo Euromedis's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labo Euromedis's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's Cash-to-Debt falls into.



Labo Euromedis Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Labo Euromedis's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Labo Euromedis's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis  (LTS:0I0L) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Labo Euromedis Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis (LTS:0I0L) Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (LTS:0I0L) Headlines

No Headlines